A Phase 4 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety of 1 New 6:2 Influenza Virus Reassortant in Adults
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 28 Sep 2017
At a glance
- Drugs Influenza virus vaccine live (Primary)
- Indications Influenza virus infections
- Focus Adverse reactions
- Sponsors MedImmune
- 20 Sep 2017 Planned End Date changed from 22 Dec 2017 to 21 Dec 2017.
- 20 Sep 2017 Planned primary completion date changed from 22 Dec 2017 to 21 Dec 2017.
- 20 Sep 2017 Status changed from recruiting to active, no longer recruiting.